3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Status
Unknown
3
Recruiting
3
Not yet recruiting
3
Active not recruiting
3
Terminated
2
Completed
2
Withdrawn
1
Approved for marketing
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
13
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
HER2-positive Breast Cancer
2
Triple Negative Breast Neoplasms
1
Thrombocytosis
1
Solid Tumor
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia
1
Lymphoma, Non-Hodgkin
1
Locally Advanced Breast Cancer
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Hematologic Neoplasms
1
HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
1
Interventions
Trastuzumab
4
pertuzumab
2
Docetaxel
2
palbociclib
1
Protons
1
Paclitaxel
1
Letrozole
1
Fulvestrant
1
Enfuvirtide
1
Doxorubicin
1
Cyclophosphamide
1
Capecitabine
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
HER2-positive Breast Cancer
×
pertuzumab
×
Clear all
NCT02379585
2018-04-24
STEFNE
Western Regional Medical Center
Phase 1/2
Terminated
8 enrolled
1 chart
NCT02345772
2018-02-20
Neohttp
Western Regional Medical Center
Phase 1/2
Terminated
4 enrolled
1 chart